The Consumer Healthcare Products Association (CHPA) issued the following statement today following the introduction of S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act.
CHPA issued the following statement today following the introduction of S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act, sponsored by Senators Johnny Isakson (R-Ga.) and Bob Casey (D-Pa.).
Today, the House Ways and Means Committee took an important step toward reinstating consumers’ ability to purchase OTC medicines with tax-preferred savings accounts, including FSAs and HSAs.
On behalf of the Health Choices Coalition, we write to applaud efforts to restore OTC medications to full tax-preferred status, eliminating the need to first obtain a prescription.
It only took a moment for Sugey and Carlos’s toddler to accidentally swallow medicine that was left within his reach. It can happen to anyone. Take 90 seconds to watch their story, and learn how to keep your family safe.
CHPA thanks Senator Isakson for his decades of service to the country and the U.S. Senate. We offer him our deepest gratitude for his steadfast dedication to better healthcare for millions of American consumers.
Scilex Citizen Petition requesting that FDA remove from the market and prevent further marketing of lidocaine-containing drug products that have not been approved pursuant to a new drug application or an abbreviated new drug application submitted under 21 U.S.C. § 355.
The Personal Care Products Council and Consumer Healthcare Products Association submitted comments to the U.S. Food & Drug Administration (FDA) in response to the Sunscreen Tentative Final Monograph.
These comments are submitted as supporting evidence for the safety of the spray dosage from of sunscreens and is referenced in the comments filed to this docket by PCPC and CHPA.
